Intrinsiqs

Is Kymera Therapeutics, Inc. overvalued?

Kymera Therapeutics, Inc. (KYMR) — key valuation metrics and fundamentals.

No verdict
Price
$109.96
Fair value
Current P/E
Normal P/E
Market cap
$8.89B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares KYMR's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.